Navigation Links
Tay-Sachs Disease Stem Cell Gene Enzyme Treatment
Date:11/10/2010

SARASOTA, Fla., Nov. 10, 2010 /PRNewswire/ -- StemCellRegenMed, Inc. announces that a new stem cell gene and enzyme replacement treatment has been performed on a fourteen month old child with Tay-Sachs disease on November 2, 2010. Tay-Sachs is a devastating disease that afflicts children primarily of parents of Jewish heritage and in very rare cases families of Eastern European background and the Cajun region in the U.S.A. The children appear normal at birth but about six months of age they lose their ability to turn over both ways; raise their heads or crawl. They become hypotonic and even have difficulty in swallowing and sucking. Between 15-18 months they may become blind and lose their hearing. Death may occur by two years of age.

The procedure was performed at a major hospital in Lima, Peru under the supervision of Burton Feinerman, M.D. trained at the Mayo Clinic in Rochester, MN and Javier Paino, M.D., Ph.D neurosurgeon and scientist trained at Mt. Sinai Hospital, N.Y. and George Washington University School of Medicine.

The therapy consisted of administration of neuron stem cells mixed with brain derived neurotrophic factor, glial derived neurotrophic factor, nerve growth factor into the central nervous system via the spinal canal to the brain and spinal cord. This procedure was repeated again in two days.

Following this an agent was started orally and given twice daily to increase the levels of an enzyme B-hexosaminidase A. This enzyme is absent or very low in patients with Tay-Sachs leading to a defect in glycolysis that results in an abnormal accumulation of fatty substances in the brain and spinal cord causing damage to the nervous system, hearing and visual centers.

The baby, Aspen Brown, has tolerated all aspects of the treatment well.  Both parents have noted movement of the head and neck that had been completely restricted; the child follows moving objects; muscle tone has improved; grasp reflex seems better all of which occurred in two to four days after treatment. Plans are now being developed to introduce the Hexa A gene with a vector or possibly work with developing a induced silenced complex RNA.

For further information contact Burton Feinerman, M.D. at 1-888-620-0411 or (941)388-2277.  E-mail contact at info@stemcellregenmed.com or bfeinerman@hotmail.com


'/>"/>
SOURCE StemCellRegenMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinsons Disease
2. Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports
3. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
4. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
5. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
6. 550 People Across Europe Will Die Today From a Preventable Lung Disease
7. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
8. Major disease-vector mosquito reveals the secrets of its immune system
9. Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinsons Disease
10. Gladstone scientists identify strategy to reduce toxic proteins associated with Alzheimers disease
11. Prometheus and Tarrot Laboratories Collaborate to Identify Markers Associated With Response to Anti-TNF Therapies in Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):